Over 30 Years of Omeprazole

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Omeprazole has been a cornerstone therapy for acid peptic diseases (APDs) for three decades.
• It is a first-line treatment for various conditions including ulcers and gastroesophageal reflux disease (GERD).

Approach:

• This literature review compares the efficacy and safety of omeprazole against other proton pump inhibitors (PPIs).
• It also assesses omeprazole's effectiveness in special populations like pediatric and geriatric patients.

Key Points:

• Omeprazole demonstrates superior efficacy among PPIs due to rapid action and antioxidant properties.
• It effectively manages nocturnal acid breakthrough and shows proven safety and tolerance in clinical trials.
• Omeprazole is effective in managing APDs in pediatric and geriatric populations.

Conclusions:

• Omeprazole is the established, prototypical drug for managing APDs.
• Despite newer alternatives, omeprazole remains the preferred choice for APD management after 30 years of use.